These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1483497)

  • 21. Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children.
    Levy G; Koysooko R
    J Pediatr; 1975 May; 86(5):789-93. PubMed ID: 1133663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of sustained-release theophylline in nocturnal asthma.
    Freeman W; Packe GE; Cayton RM
    Br J Clin Pract; 1991; 45(1):21-5. PubMed ID: 1931534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theophylline in maintenance treatment of chronic asthma: concentration-dependent additional effect to beta 2-agonist therapy.
    Billing B; Dahlqvist R; Hörnblad Y; Leideman T; Skareke L; Ripe E
    Eur J Respir Dis; 1987 Jan; 70(1):35-43. PubMed ID: 2880747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sustained release theophylline given at three different evening intake times in addition to a baseline medication.
    Siebert B; Kunkel G; Borner K; Staudinger HW; Steinijans VW
    Eur Respir J; 1990 Feb; 3(2):176-81. PubMed ID: 2178965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous theophylline after beta 2-agonist treatment in severe acute asthma. Effect on patients who are not pre-treated with theophylline.
    Janson C; Boman G
    Ups J Med Sci; 1992; 97(2):149-55. PubMed ID: 1471314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans.
    Müller M; Brunner M; Schmid R; Putz EM; Schmiedberger A; Wallner I; Eichler HG
    Life Sci; 1998; 62(15):PL227-34. PubMed ID: 9566779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic profile of meropenem, administered at 500 milligrams every 8 hours, in plasma and cantharidin-induced skin blister fluid.
    Maglio D; Teng R; Thyrum PT; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2003 May; 47(5):1771-3. PubMed ID: 12709358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
    Vilsvik JS; Persson CG; Amundsen T; Brenna E; Naustdal T; Syvertsen U; Storstein L; Källén AG; Eriksson G; Holte S
    Eur Respir J; 1990 Jan; 3(1):27-32. PubMed ID: 2311727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained release theophylline in nocturnal asthma.
    Elias-Jones AC; Higenbottam TW; Barnes ND; Godden DJ
    Arch Dis Child; 1984 Dec; 59(12):1159-61. PubMed ID: 6395810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and skin blister fluid concentrations of metronidazole and its hydroxy metabolite after oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Pol J Pharmacol; 1996; 48(1):47-52. PubMed ID: 9112627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous intravenous therapy with theophylline in a patient with brittle bronchial asthma.
    Speelberg B; van den Brink WT
    Eur Respir J; 1988 May; 1(5):471-2. PubMed ID: 3169219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations.
    Sun HK; Ong CT; Umer A; Harper D; Troy S; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1629-32. PubMed ID: 15793157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum levels and bronchodilatation after intravenous administration of theophylline in asthmatic patients].
    Andrejak M; Lary H; Aubry P; Levi-Valensi P
    Rev Pneumol Clin; 1986; 42(2):82-6. PubMed ID: 3749701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusion.
    Mouton JW; Michel MF
    J Antimicrob Chemother; 1991 Dec; 28(6):911-8. PubMed ID: 1816187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of the therapeutic range of serum theophylline concentration in the treatment of an attack of bronchial asthma.
    Nakahara Y; Murata M; Suzuki T; Ohtsu F; Nagasawa K
    Biol Pharm Bull; 1996 May; 19(5):710-5. PubMed ID: 8741580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unstable asthma and theophylline.
    Stern M; Geddes DM; Collins JV; Evans T
    BMJ; 1991 Nov; 303(6813):1317-9. PubMed ID: 1747676
    [No Abstract]   [Full Text] [Related]  

  • 37. [Syphilitic antibodies in the blister fluid of cantharides cerate].
    BINAZZI M; MARCHINI E
    Ann Ital Dermatol Sifilogr; 1950; 5(3):151-82. PubMed ID: 14777420
    [No Abstract]   [Full Text] [Related]  

  • 38. Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison.
    Laursen LC; Eriksson G; Weeke B
    Respiration; 1986; 50(1):57-61. PubMed ID: 3523664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of theophylline withdrawal on airway inflammation in asthma.
    Minoguchi K; Kohno Y; Oda N; Wada K; Miyamoto M; Yokoe T; Hashimoto T; Akabane T; Kobayashi H; Mita S; Kihara N; Adachi M
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():57-63. PubMed ID: 9756188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human plasma and skin blister fluid levels of griseofulvin after its repeated administration.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(3):351-4. PubMed ID: 4076331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.